What is the share price of Ahlcon Parenterals (India) Ltd (524448)?

Company share prices are keep on changing according to the market conditions. The current trading price of Ahlcon Parenterals (India) Ltd (524448) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Ahlcon Parenterals (India)?

The latest standalone P/E ratio of Ahlcon Parenterals (India) as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Ahlcon Parenterals (India) Ltd (524448)?

The latest standalone P/B ratio of Ahlcon Parenterals (India) Ltd (524448) as of 01-Jan-1970 is 4.31.

What is the 52-week high and low of Ahlcon Parenterals (India) Ltd (524448)?

The 52-week high of Ahlcon Parenterals (India) Ltd (524448) is Rs. 517.25 and the 52-week low is Rs. 514.75.

Ahlcon Parenterals (India) Ltd (524448) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Ahlcon Parenterals (India) Ltd (524448)
Brand: Ahlcon Parenterals (India)

Ahlcon Parenterals (India) Ltd (524448)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524448 NSE: Pharmaceuticals & Drugs | Small Cap | Ahlcon Parenteral (I Share Price

Ahlcon Parenterals (India) Ltd (524448)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524448 NSE: Pharmaceuticals & Drugs | Small Cap | Ahlcon Parenteral (I Share Price

Key Metrics

Valuation Multiples

Market Cap

₹371 Cr.

Current Price

₹0

52-Week Low / High

₹515 / 517

TTM EPS

₹-27.5

TTM Sales

₹176 Cr.

Book Value per Share

₹119.5

P/E Ratio

0.00

Industry PE

48.5

Price to Book (P/B)

4.31

Price to Sales (P/S)

2.11

EV/EBITDA

22.20

Dividend Yield

NAN%

Profitability Efficiency

Return on Equity (ROE)

0.00%

Return on Capital Employed (ROCE)

2.65%

Return on Assets (ROA)

-7.33%

Operating Profit Margin

15.2%

Net Profit Margin

-11.26%

Gross Profit Margin

3.2%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

32.77%

Operating Profit Growth (1 Year)

Improving versus 3-year growth rate

504.07%

Net Profit Growth (1 Year)

Asset Quality

Promoter Holding

93.26%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹79 Cr.

Equity

₹7.2 Cr.

Face Value

₹10

All Time Low / High

₹2.00 / 598.00

Ahlcon Parenterals (India) stock performance

Key Ratios

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	TTM
ROCE % ⓘ	31.5%	33.5%	10.4%	-2.3%	1.1%	-5%	-6.7%	4.7%	-8.9%	2.7%	-
Value Creation Index ⓘ	1.3	1.4	-0.3	-1.2	-0.9	-1.4	NA	NA	NA	NA	-
Growth Parameters ⓘ
Sales ⓘ	108	120	116	119	135	150	156	174	132	176	176
Sales YoY Gr.	-	11.4%	-3.3%	2.6%	13.8%	10.5%	4%	12.1%	-24.2%	32.8%	-
Adj EPS ⓘ	17.7	27.1	24.6	-19.2	-11.8	-62.6	-67.1	-20.8	-64.6	-28.1	-27.5
YoY Gr.	-	53.3%	-9.2%	-178.1%	NA	NA	NA	NA	NA	NA	-
BVPS (₹) ⓘ	75.1	102.1	124.8	99	79.8	19.5	-46.6	-68.2	-133.5	-161	119.5
Adj Net Profit ⓘ	12.7	19.5	17.7	-13.8	-8.5	-45	-48.3	-15	-46.5	-20.2	-20
Cash Flow from Ops. ⓘ	9.3	17.1	31.2	7.8	12.7	34.7	38.7	30.3	21.4	11.5	-
Debt/CF from Ops. ⓘ	1.9	2.5	6.6	32.1	21.5	8.3	7.6	9.9	14.6	29.6	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	5.6%	5.4%	4.1%	32.8%
Adj EPS ⓘ	-205.3%	NA	NA	NA
BVPSⓘ	-208.8%	-215.1%	NA	NA
Share Price	-	-	-	-

Key Financial Parameters ⓘ

	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	TTM
Return on Equity % ⓘ	26.2	30.4	21.7	-17.2	-13.1	-126	496.3	36.2	64.1	19.1	132.5
Op. Profit Mgn % ⓘ	22.9	28.7	23.1	12.6	19.8	12.8	7.7	18.9	3.9	15.2	25.6
Net Profit Mgn % ⓘ	11.8	16.3	15.3	-11.6	-6.3	-30.1	-31.1	-8.6	-35.2	-11.5	-11.3
Debt to Equity ⓘ	0.3	0.6	2.3	3.5	4.8	20.6	-8.8	-6.1	-3.3	-2.9	-
Working Cap Days ⓘ	107	122	149	152	140	141	153	137	149	117	90
Cash Conv. Cycle ⓘ	55	67	86	103	101	90	83	76	82	66	19

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22
Sales	107.71	119.97	115.98	119	135.39	149.66	155.65	174.47	132.31	175.67
Operating Expenses ⓘ +	83.40	85.62	90.25	110.71	116.27	130.54	143.79	142.37	127.89	148.96
Manufacturing Costs	29.63	31.44	37.11	21.51	23.83	39.38	43.68	43.78	41.59	47.78
Material Costs	29.11	27.13	22.43	40.94	46.07	50.21	48.53	54.69	47.30	62.39
Employee Cost	14.57	15.88	17.67	22.45	24.56	22.38	24.11	26.14	23.69	26.18
Other Costs ⓘ	10.09	11.16	13.04	25.81	21.81	18.57	27.48	17.76	15.30	12.62
Operating Profit ⓘ	24.30	34.35	25.74	8.29	19.12	19.11	11.86	32.10	4.42	26.70
Operating Profit Margin (%)	22.6%	28.6%	22.2%	7.0%	14.1%	12.8%	7.6%	18.4%	3.3%	15.2%
Other Income ⓘ +	0.95	0.74	0.39	0.64	0.65	4.03	1.83	1.47	1.41	4.61
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	2.95	1.58	0.63	16.57	17.29	27.57	28.59	27.54	26.16	25.63
Depreciation ⓘ	3.61	3.44	4.61	16.13	16.30	38.99	32.68	21.61	26.70	25.47
Profit Before Tax ⓘ	18.69	30.06	20.89	-23.77	-13.82	-43.42	-47.57	-15.59	-47.03	-19.79
Tax ⓘ	5.82	10.56	3.87	-5.24	0	0	0	0	0	0
Profit After Tax	12.87	19.50	17.02	-18.53	-13.82	-43.42	-47.57	-15.59	-47.03	-19.79
PAT Margin (%)	12.0%	16.3%	14.7%	-15.6%	-10.2%	-29.0%	-30.6%	-8.9%	-35.5%	-11.3%
Adjusted EPS (₹)	17.8	27.0	23.6	-25.7	-19.2	-60.3	-66.1	-21.7	-65.3	-27.5
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Ahlcon Parenteral (I - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22
Equity and Liabilities
Shareholders Fund +	54.99	73.54	89.82	71.29	57.47	14.05	-33.53	-49.11	-96.14	-115.93
Share Capital ⓘ	8.10	7.20	7.20	7.20	7.20	7.20	7.20	7.20	7.20	7.20
Reserves ⓘ	46.88	66.34	82.62	64.09	50.26	6.85	-40.73	-56.31	-103.34	-123.13
Debt +	13.01	40.20	206.16	250.70	273.57	188.92	295.79	301.27	245.40	339.30
Long Term Debt	2.92	20.02	181.76	182.08	100	94.65	75	143	75	253
Short Term Debt	10.09	20.18	24.40	68.62	173.57	94.27	220.79	158.27	170.40	86.30
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	8.70	10.01	7.60	6.37	4.14	14.12	14.33	14.50	11.17	8.89
Others Liabilities ⓘ	18.01	18.80	34.75	30.57	27.73	114.53	43.98	27.37	104.72	42.73
Total Liabilities ⓘ	94.71	142.56	338.34	358.92	362.91	331.62	320.58	294.04	265.15	275
Fixed Assets
Net Fixed Assets ⓘ +	46.50	49.83	277.72	289.23	275.04	267.85	245.81	232.60	210.60	194.52
Gross Block	83.22	89.83	323.45	351.09	353.14	381.76	390.59	398.48	403.17	409.67
Accumulated Depreciation	36.72	40	45.73	61.86	78.11	113.91	144.78	165.87	192.57	215.15
CWIP ⓘ	7.73	26.30	3.21	10.83	27.45	4.08	2.75	1.26	6.22	0.62
Investments ⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	10.09	7.74	13.61	21.52	17.07	17.53	26.95	25.54	19.36	25.90
Trade Receivables	25.69	33.53	31.30	26.12	33.21	25.26	28.42	24.14	14.92	24.27
Cash Equivalents	0.58	17.08	0.86	1.76	0.53	0.55	0.61	0.40	0.31	15.13
Others Assets ⓘ	4.12	8.06	11.64	9.45	9.60	16.35	16.04	10.10	13.74	14.56
Total Assets ⓘ	94.71	142.56	338.34	358.92	362.91	331.62	320.58	294.04	265.15	275

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22
Cash Flow From Operating Activity ⓘ +	9.31	17.13	31.17	7.80	12.73	34.67	38.74	30.33	21.42	11.47
PBT ⓘ	18.69	30.06	20.89	-23.77	-13.82	-43.42	-47.57	-15.59	-47.03	-19.79
Adjustment ⓘ	7.82	4.34	6.22	33.83	33.80	80.80	74.50	50.57	56.01	50.84
Changes in Working Capital ⓘ	-9.59	-6.27	10.67	-1.82	-6.77	-2.46	12.44	-5.24	12.11	-19.24
Tax Paid ⓘ	-4.81	-9.60	-6.33	-0.44	-0.48	-0.25	-0.62	0.59	0.32	-0.34
Cash Flow From Investing Activity ⓘ +	-4.73	-25.23	-210.76	-34.96	-18.64	-9.81	-9.32	-9.18	-7.78	-3.68
Capex	-5.04	-25.47	-210.52	-35.26	-18.73	-10	-9.48	-9.35	-7.91	-3.79
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0.32	0.24	-0.24	0.30	0.08	0.19	0.15	0.17	0.13	0.11
Cash Flow From Financing Activity ⓘ +	-5.66	24.76	163.09	28.28	4.64	-24.80	-29.35	-21.36	-13.85	7.07
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-4.10	15.68	158.87	0.31	0	0	-25	0	0	0
Interest Paid ⓘ	0	0	0	-16.25	-18.46	-27.35	-36.22	-26.84	-25.98	-18.83
Dividend Paid ⓘ	-0.02	-0.11	0	0	0	0	0	0	0	0
Others ⓘ	-1.55	9.19	4.22	44.22	23.10	2.55	31.87	5.48	12.13	25.90
Net Cash Flow ⓘ	-1.08	16.66	-16.50	1.12	-1.27	0.05	0.07	-0.21	-0.21	14.86

Financial Ratio

PARTICULARS	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22
Ratios
ROE (%)	26.98	30.56	20.83	-23.01	-21.47	-121.43	N/A	N/A	N/A	N/A
ROCE (%)	31.48	33.5	10.43	-2.33	1.06	-5	N/A	N/A	N/A	N/A
Asset Turnover Ratio	1.32	1.12	0.54	0.39	0.42	0.44	0.48	0.57	0.47	0.65
PAT to CFO Conversion(x)	0.72	0.88	1.83	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	59.40	81.10	91.40	76.90	71.30	69.40	62.90	55	53.90	40.70
Inventory Days	30.50	24.40	30.10	47	46.30	41.10	52.20	54.90	61.90	47
Payable Days	96.90	125.90	143.40	62.30	41.70	66.40	107	96.20	99	58.70

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Ahlcon Parenterals (India) Ltd FAQs

The current trading price of Ahlcon Parenteral (I on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Ahlcon Parenteral (I stood at ₹370.8 Cr

The latest P/E ratio of Ahlcon Parenteral (I as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Ahlcon Parenteral (I as of 31-Dec-1969 is 4.31.

The 52-week high of Ahlcon Parenteral (I is ₹517.2 and the 52-week low is ₹514.8.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Ahlcon Parenteral (I is ₹176 ( Cr.) .

Data is not available for this company.

No data found

About Ahlcon Parenterals (India) Ltd

Ahlcon Parenterals (India), incorporated in 1992, is engaged in manufacturing life saving Intravenous fluids and medical disposals by employing a highly sophisticated production process, the aseptic form-fill-seal technology imported from Switzerland.

Ahlcon has an installed capacity of 30 million bottles per annum for LVP in pack size of 100ml and 500ml. Further, 200ml and 300ml packs are being launched in near future.

The company also has capacity of 60 million vials of eye drops and injections in the fill size of 2ml, 3ml, 5ml & 10ml both in transparent and white opaque packs as SVP.

Within a short span of time since its inception, the company has achieved the quality certification from WHO-GMP International and ISO 9002, a landmark achievement which ensures international quality standards with ultimate objective of getting the MCA approval.

Products

Antimicrobial I V fluids, eye and ear drops, ointments, other products such as respiratory solutions, plasma volume expander and many more.

Ahlcon Parenterals (India) Ltd (524448)

Ahlcon Parenterals (India) Ltd (524448)

Ahlcon Parenterals (India) stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Ahlcon Parenteral (I - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Ahlcon Parenterals (India) Ltd FAQs

About Ahlcon Parenterals (India) Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Ahlcon Parenterals (India) Ltd (524448)

Ahlcon Parenterals (India) Ltd (524448)

Ahlcon Parenterals (India) stock performance

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Ahlcon Parenteral (I - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Ahlcon Parenterals (India) Ltd FAQs

What is the share price of Ahlcon Parenteral (I?

What is the market cap of Ahlcon Parenteral (I?

What is the P/E ratio of Ahlcon Parenteral (I?

What is the P/B ratio of Ahlcon Parenteral (I?

What is the 52-week high and low of Ahlcon Parenteral (I?

What is the TTM revenue of Ahlcon Parenteral (I?

Is a good quality company?

Is undervalued or overvalued?

Is a good buy now?

About Ahlcon Parenterals (India) Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.